| Pharmaceutical Economics and Policy | Lifetime | 4 | US 4 | 99.63 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 29 | US 14 | 99.86 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 10 | US 8 | 99.65 |
| Medication Adherence and Compliance | Lifetime | 6 | US 5 | 99.73 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 4 | US 2 | 99.44 |
| Statistical Methods in Clinical Trials | Lifetime | 13 | US 7 | 99.58 |
| Advanced Causal Inference Techniques | Lifetime | 8 | US 7 | 99.46 |
| Pharmaceutical studies and practices | Lifetime | 45 | US 32 | 99.28 |
| Chronic Disease Management Strategies | Lifetime | 97 | US 42 | 98.98 |
| Diabetes Treatment and Management | Lifetime | 238 | US 101 | 99.01 |
| Healthcare Policy and Management | Lifetime | 326 | US 239 | 98.27 |
| Inflammatory mediators and NSAID effects | Lifetime | 327 | US 159 | 97.92 |
| Primary Care and Health Outcomes | Lifetime | 303 | US 182 | 98.13 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 492 | US 191 | 97.79 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 538 | US 143 | 97.85 |
| Medical Coding and Health Information | Lifetime | 64 | US 26 | 94.94 |
| Meta-analysis and systematic reviews | Lifetime | 511 | US 156 | 94.10 |
| Pharmaceutical industry and healthcare | Lifetime | 276 | US 166 | 91.74 |
| Healthcare cost, quality, practices | Lifetime | 892 | US 478 | 91.26 |
| Statistical Methods in Clinical Trials | 2021-2025 | 1 | US 1 | 99.39 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 21 | US 7 | 99.49 |
| Advanced Causal Inference Techniques | 2021-2025 | 4 | US 4 | 98.77 |
| Diabetes Treatment and Management | 2021-2025 | 111 | US 51 | 98.72 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 113 | US 39 | 96.05 |
| Meta-analysis and systematic reviews | 2021-2025 | 105 | US 16 | 94.22 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 606 | US 212 | 91.76 |
| Dermatology and Skin Diseases | 2021-2025 | 780 | US 178 | 89.24 |
| Medication Adherence and Compliance | 2021-2025 | 296 | US 113 | 84.95 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 151 | US 24 | 83.21 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 941 | US 310 | 45.31 |
